Treace Medical Concepts Inc (TMCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 44,455 | 51,108 | 62,212 | 40,758 | 41,953 |
| Cost of Goods | 8,781 | 10,127 | 11,469 | 7,998 | 7,675 |
| Gross Profit | 35,674 | 40,981 | 50,743 | 32,760 | 34,278 |
| Operating Expenses | 57,837 | 60,076 | 57,994 | 51,576 | 48,005 |
| Operating Income | -21,382 | -18,968 | -6,782 | -17,818 | -13,052 |
| Interest Expense | 1,312 | 1,317 | 1,304 | 1,296 | 1,282 |
| Other Income | 1,488 | 1,609 | 1,805 | 1,593 | 2,063 |
| Pre-tax Income | -21,206 | -18,676 | -6,281 | -17,521 | -12,271 |
| Net Income Continuous | -21,206 | -18,676 | -6,281 | -17,521 | -12,271 |
| Net Income | $-21,206 | $-18,676 | $-6,281 | $-17,521 | $-12,271 |
| EPS Basic Total Ops | -0.34 | -0.30 | -0.10 | -0.28 | -0.20 |
| EPS Basic Continuous Ops | -0.34 | -0.30 | -0.10 | -0.28 | -0.20 |
| EPS Diluted Total Ops | -0.34 | -0.30 | -0.10 | -0.28 | -0.20 |
| EPS Diluted Continuous Ops | -0.34 | -0.30 | -0.10 | -0.28 | -0.20 |
| EPS Diluted Before Non-Recurring Items | -0.34 | -0.30 | -0.10 | N/A | N/A |
| EBITDA(a) | $-19,542 | $-17,319 | $-5,314 | $-16,547 | $-12,249 |